Modafinil?

What are the key factors driving the demand for Modafinil?

Modafinil is a wakefulness-promoting agent used to treat disorders such as narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea [1]. The growing demand for Modafilil is largely attributed to its off-label use for cognitive enhancement and attention deficit hyperactivity disorder (ADHD) treatment.

How does Modafinil compare to other wakefulness-promoting agents?

Modafinil has been shown to have a unique mechanism of action, distinct from other wakefulness-promoting agents like amphetamines [2]. Its effectiveness and safer side-effect profile have made it a popular choice among patients and healthcare professionals.

What are the side effects associated with Modafinil use?

Common side effects of Modafinil include headache, nausea, dizziness, and insomnia. However, it can also cause more serious side effects such as anxiety, depression, and skin reactions in rare cases [3].

What is the patent status of Modafinil?

Modafinil was first patented in 1986, but the patent has since expired. According to DrugPatentWatch.com, the patent for the generic versions of Modafinil expired in 2015 [4], allowing for the production and distribution of generic versions.

Can patients obtain Modafinil without a prescription in certain countries?

Yes, patients in some countries, such as Mexico and Turkey, are able to purchase Modafinil without a prescription. However, this practice is subject to various regulations and should be approached with caution.

Sources:

[1] National Center for Biotechnology Information. (2020). Modafinil.

[2] European Medicines Agency. (2019). Modafinil.

[3] MedlinePlus. (2022). Modafinil.

[4] DrugPatentWatch.com. (n.d.). Modafinil Patent Expiration.